Lipitor, Atorvastatin

Lipitor, Atorvastatin Newswire

Comprehensive Real-Time News Feed for Lipitor, Atorvastatin (generic).

Results 1 - 20 of 203 in Lipitor, Atorvastatin (generic)

  1. Lipitor Lawsuits Move Forward, as Judge Prepares to Select Cases for...Read the original story w/Photo

    Friday | PRWeb

    The Firm is representing Lipitor lawsuit plaintiffs who allegedly developed Type 2diabetes due to their use of the statin medication. We look forward to the start of bellwether trials, as the outcome of these cases could provide valuable insight into jury decisions in similar Lipitor diabetes claims.

    Comment?

  2. After heart attacks, most don't get enough statinsRead the original story w/Photo

    Friday | Fox News

    In the U.S., less than a third of older heart "event" patients being discharged from the hospital get the recommended high-intensity statins, according to a new study that looked at prescriptions filled. National guidelines from the American College of Cardiology and American Heart Association say the majority of patients should be on a high-dose statin following a serious heart disease-related event like heart attack or bypass surgery.

    Comment?

  3. 70 Percent of Heart Patients Don't Take Recommended StatinsRead the original story w/Photo

    Thursday Jan 29 | News Max

    In the U.S., less than a third of older heart "event" patients being discharged from the hospital get the recommended high-intensity statins, according to a new study that looked at prescriptions filled. National guidelines from the American College of Cardiology and American Heart Association say the majority of patients should be on a high-dose statin following a serious heart disease-related event like heart attack or bypass surgery.

    Comment?

  4. Cutting down on prescription drug costsRead the original story w/Photo

    Thursday Jan 29 | WPTV Local News

    You may have had sticker shock the last time you picked up a prescription - that happens with changes in drug prices or your insurance coverage. Prices can also vary drastically by store.

    Comment?

  5. Cholesterol-lowering statin drugs raise risk of cataracts, new study suggestsRead the original story w/Photo

    Wednesday Jan 28 | National Post

    The millions of Canadians taking cholesterol-lowering statin drugs are at heightened risk of contracting cataracts, concludes a new study that adds fuel to heated debate over one of the world's most widely used medications. People on statins are as much as 30% more likely to develop the eye disease than those not taking the pills, suggested the University of British Columbia analysis of hundreds of thousands of patients in U.S. and Canadian health databases.

    Comment?

  6. Statins may benefit women as much as menRead the original story

    Wednesday Jan 28 | WNFL-AM Green Bay

    A large international analysis finds that statin drugs reduce heart risk factors like high cholesterol as effectively in women as they do in men. The results, based on pooled data from 22 clinical trials, include a finding that reductions in deaths from any cause were similar for men and women taking statins.

    Comment?

  7. The One Thing Pfizer, Inc. Shareholders Should Worry About, and One They Shouldn'tRead the original story w/Photo

    Wednesday Jan 28 | The Motley Fool

    The company reported its fourth-quarter earnings results before the opening bell on Tuesday, delivering a 3% decline in sales to $13.12 billion from Q4 2013 and reporting a 4% decline in adjusted profit per share to $0.54. Comparably, though, these results were favorable compared to Wall Street's very timid expectations of $12.9 billion in sales and just $0.53 in EPS for Q4.

    Comment?

  8. statin drugsRead the original story

    Feb 29, 2012 | InteliHealth

    Statins are a group of drugs prescribed to lower cholesterol, protect against damage from coronary-artery disease and prevent heart attack. Should you be taking statins? Statins are a group of drugs prescribed to lower cholesterol, protect against damage from coronary-artery disease and prevent heart attack.

    Comment?

  9. Regeneron/Sanofi cholesterol drug gets FDA priority reviewRead the original story

    Sunday Jan 25 | Reuters

    Regeneron Pharmaceuticals on Monday said U.S. health regulators accepted its application to review a potent cholesterol drug on a priority basis, potentially giving it the upper hand in a fierce race with Amgen to bring a new medicine from the promising class to market. Regeneron, which is developing the drug, alirocumab, in partnership with Sanofi, said the target date for a Food and Drug Administration approval decision was July 24, following a six-month review period.

    Comment?

  10. Protecting heart surgery patients' kidney health with high-dose statinRead the original story w/Photo

    Thursday Jan 22 | Medical News Today

    Acute kidney injury often arises after major surgery because the kidneys can be deprived of normal blood flow during the procedure. The use of contrast media, or dyes, can contribute to this problem.

    Comment?

  11. Lipitor Lawsuit News: Discovery Moves Ahead in Federal Multidistrict...Read the original story w/Photo

    Wednesday Jan 21 | PRWeb

    The Firm is currently representing clients in Lipitor lawsuits who allegedly developed new-onset Type 2 diabetes due to their use of the statin medication. Our Firm is currently investigating a number of claims on behalf of individuals who allegedly developed diabetes due to their use of Lipitor.

    Comment?

  12. Is your cholesterol really too high?Read the original story w/Photo

    Tuesday Jan 20 | Inside Bay Area

    There is an International Network of Cholesterol Skeptics - a group of scientists, physicians, other academicians and science writers from various countries - who offer this food for thought.

    Comment?

  13. Lipitor Lawsuit News: Lipitor Lawsuits Conference Scheduled For This...Read the original story w/Photo

    Tuesday Jan 20 | PRWeb

    Lipitor Lawsuits Pending In A Multidistrict Litigation In The U.S. District Court, District of South Carolina Allege That Plaintiffs Who Use The Cholesterol-Lowering Medication Develop Type 2 Diabetes.

    Comment?

  14. High-Dose Statin May Protect Heart Surgery Patients' Kidney HealthRead the original story

    Tuesday Jan 20 | Scientific Blogging

    Acute kidney injury often arises after major surgery because the kidneys can be deprived of normal blood flow during the procedure. The use of contrast media, or dyes, can contribute to this problem.

    Comment?

  15. High-dose atorvastatin is superior to moderate-dose simvastatin in...Read the original story

    Sunday Jan 18 | CiteULike

    To study whether high-dose versus usual-dose statin treatment reduces the incidence of peripheral artery disease and what is the effect of high-dose statin treatment on cardiovascular disease outcome in patients with PAD. In the Incremental Decrease in End Points Through Aggressive Lipid Lowering trial, 8888 post-myocardial infarction patients were randomised to high-dose or usual-dose statin therapy .

    Comment?

  16. More than 1,600 Lipitor Lawsuits Now Included in South Carolina...Read the original story

    Sunday Jan 18 | PRWeb

    The Firm is currently representing numerous plaintiffs in Lipitor lawsuits that allege new-onset Type 2 diabetes caused by the cholesterol-lowering statin medication. More than 100 new Lipitor lawsuits were filed over the past month in a federal litigation that continues to move forward in the U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports.

    Comment?

  17. 3 Big Pharma Stocks With More Free Cash Flow Than Gilead Sciences Inc.Read the original story w/Photo

    Sunday Jan 18 | The Motley Fool

    That's a compound annual growth rate of 33.8%, in case you were interested. Although Gilead has a broad portfolio of products spanning a wide gambit of infectious diseases, and even includes cardiovascular and oncology products, the bulk of its growth prospects lie with a trio of approved drugs: Harvoni, Sovaldi, and Stribild.

    Comment?

  18. Can You Guess Which Big Pharma Has a More Robust Pipeline Than Pfizer, Inc.?Read the original story w/Photo

    Thursday Jan 15 | The Motley Fool

    Of course, that isn't for a lack of trying on the part of management. Pfizer's trials and tribulations Pfizer was wildly successful in the 1990s due in part to its broad product portfolio of drugs, led by cholesterol-lowering medication Lipitor.

    Comment?

  19. Severe hepatic injury associated with different statinsRead the original story

    Tuesday Jan 13 | GastroHep.com

    A study in the most recent issue of the Journal of Gastroenterology & Hepatology investigates severe hepatic injury associated with different statins in patients with chronic liver disease. In this study, Dr Jou-Wei Lin and colleagues from Taiwan estimated the risk of severe hepatic injury associated with different statins in patients with chronic liver disease.

    Comment?

  20. Short term high dose statin use in acute coronary syndromeRead the original story

    Monday Jan 12 | Notes from Dr. RW

    From a recent meta-analysis : The use of short-term high-dose atorvastatin pretreatment is safe and significantly improves the final TIMI flow grade as well as reduces the 30-day MACEs in ACS patients post-PCI.

    Comment?